Evidence map›Paper›PMID 40304259›Full record

ArticleAnalytical chemistry2025

Accelerating Cleavage Activity of CRISPR-Cas13 System on a Microfluidic Chip for Rapid Detection of RNA.

Jongmin Kim, Ajymurat Orozaliev, Sarah Sahloul, Anh-Duc Van, Van-Truong Dang, Van-Sang Pham, Yujeong Oh, Ibrahim Chehade, Mohamed Al-Sayegh, Yong-Ak Song

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Analytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jongmin KimDivision of Engineering, New York University Abu Dhabi, P.O. Box 129188, Abu Dhabi, UAE.ORCID 0000-0001-7464-2055
Ajymurat OrozalievDivision of Engineering, New York University Abu Dhabi, P.O. Box 129188, Abu Dhabi, UAE.
Sarah SahloulDivision of Engineering, New York University Abu Dhabi, P.O. Box 129188, Abu Dhabi, UAE.
Anh-Duc VanDivision of Engineering, New York University Abu Dhabi, P.O. Box 129188, Abu Dhabi, UAE.
Van-Truong DangSchool of Mechanical Engineering, Hanoi University of Science and Technology, No. 1 Daicoviet Road, Hanoi 100000, Vietnam.ORCID 0009-0004-6140-2051
Van-Sang PhamSchool of Mechanical Engineering, Hanoi University of Science and Technology, No. 1 Daicoviet Road, Hanoi 100000, Vietnam.
Yujeong OhDivision of Science, New York University Abu Dhabi, P.O. Box 129188, Abu Dhabi, UAE.
Ibrahim ChehadeDivision of Science, New York University Abu Dhabi, P.O. Box 129188, Abu Dhabi, UAE.
Mohamed Al-SayeghDivision of Science, New York University Abu Dhabi, P.O. Box 129188, Abu Dhabi, UAE.
Yong-Ak SongDivision of Engineering, New York University Abu Dhabi, P.O. Box 129188, Abu Dhabi, UAE.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is extremely advantageous to detect nucleic acid levels in the early phases of disease management; such early detection facilitates timely treatment, and it can prevent altogether certain cancers and infectious diseases. A simple, rapid, and versatile detection platform without enzymatic amplification for both short and long sequences would be highly desirable in this regard. Our study addresses this need by introducing IMACC, an

Indexed as

CRISPR-Cas SystemsLab-On-A-Chip DevicesMicrofluidic Analytical TechniquesMicroRNAsHumansSARS-CoV-2MicroRNAsMIRN21 microRNA, human

Identifiers

PMID40304259
PMCPMC12079638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.